AMG 333: Clinical Trials

2 trials of AMG 333, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 terminated. 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 12Completed 1, Terminated 1

Follow AMG 333: new trials by email Literature Review of AMG 333 trials Research Report on AMG 333

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Phase I, Double-Blind,Placebo, MAD Study to Evaluate the Safety, Tolerability, PK, and PD of AMG 333 in Healthy Subjects and Migraine Subjects
AMG 333, Placebo - Migraine
Phase 1TerminatedAmgen162014-05-012015-04-01
Single-Ascending Dose Study of AMG 333 in Healthy Subjects and Subjects With Migraines
AMG 333, Placebo - Migraine
Phase 1CompletedAmgen742013-10-012014-12-09

Conditions studied

Migraine Disorders (2)

Sponsors

Amgen (2)

Countries

United States (2)